Characteristics of SLE (systemic lupus erythematosus) and controls subjects.

CAD, coronary artery disease; BMI, body mass index; SELENA, safety of estrogens in lupus erythematosus national assessment; SLEDAI, systemic lupus erythematosus disease activity index; LA, lupus anticoagulant; aCL, anti-cardiolipin antibody; β2GP1, β2-Glycoprotein 1; APS, antiphospholipid syndrome.10-year risk of heart attack was calculated using the Framingham equation.Normal value for homocysteine/creatinine ratio was below 0.17.Normal value for 25(OH)-D3 vitamin was above 30 ng/ml (nanogram per liter)GRF, glomerular rate filtration, calculated with the Modification of Diet in Renal Disease (MDRD) equation and expressed in milliliters per minute per 1.73 square meters of body surface areaHormonal contraception was progestin-only pill in all cases.Other therapy included cyclophosphamide (n = 24), azathioprine (n = 14), mycophenolatemofetil (n = 11), methotrexate (n = 3), rituximab (n = 1), or intravenous immunoglobulin (n = 1)cm, centimeter; g/l, gram per liter; g, gram; millimeter of mercure, mmHgResults are shown as mean and (SD), and (range)